WELLTOWER INC. (WELL)
Assessment summary
Needs a clear valuation case to justify owning.
Compare peers
Healthcare names covered in the tracker.
Price
$232.16
Yield
1.28%
P/(A)FFO
37.20x
Payout
2.11x
Occupancy
—
Net debt / EBITDA
2.99x
Category scores
Six weighted categories make up the overall quality score. Each renders its own rationale once this name has been through a scoring pass.
Cash flow & dividend safety
FFO per share of $1.56 (quarterly) annualizes to approximately $6.24, with full-year 2026 guidance of $6.36–$6.44, indicating modest growth momentum. Payout coverage of 2.11x implies a payout ratio of roughly 47%, well below the 75% threshold, providing substantial safety margin. However, AFFO per share is not disclosed in the data, limiting precision; the company reports normalized FFO but not adjusted FFO, which is the standard metric for this rubric. The 15% dividend increase announced in July 2026 and 221 consecutive quarterly dividends demonstrate commitment, though the multi-year growth streak cannot be confirmed from available data. Strong portfolio NOI growth (15.5% SSNOI) and operational momentum support sustainability, but absence of explicit AFFO and long-term dividend history prevents a higher score.
Balance sheet
Net debt/EBITDA of 2.99x is well below the 5x threshold for a score of 5, indicating strong leverage metrics. FFO-based payout coverage of 2.11x exceeds the 2.5x minimum for a score of 3 and approaches the 4x upper bound, demonstrating solid dividend sustainability. The earnings release confirms fixed-rate debt issuance (C$1.15 billion at 3.95% weighted-average coupon in July 2026) and a laddered maturity profile with no near-term debt wall mentioned. Net debt to enterprise value improved to 8.9% from 10.1% year-over-year, and $9.5 billion of liquidity is available. While the company does not explicitly disclose credit rating, the balance sheet strength and investment-grade debt issuance activity suggest BBB+ or better standing. The score reflects excellent leverage and coverage metrics that fall slightly short of the pristine 5-anchor profile.
Operating performance
Welltower demonstrates strong operating performance well above the 3-anchor threshold. Total portfolio SSNOI grew 15.5% year-over-year in Q2 2026, significantly exceeding the +3% benchmark, with SHO portfolio SSNOI growth of 20.5%. SHO occupancy improved 330 basis points year-over-year with RevPOR growth of 5.2%, indicating positive spreads and occupancy expansion. Full-year 2026 guidance projects blended SSNOI growth of 13.75%–16.00%, with SHO expected at 18.5%–21.5%, sustaining the outsized growth trajectory. While specific occupancy percentage levels are not disclosed in the data provided, the 330 bps occupancy growth and strong RevPOR expansion suggest healthy occupancy levels with positive momentum, aligning with the 5-anchor criteria of occupancy stability at elevated levels and positive spreads.
Portfolio & sector quality
Welltower operates in seniors housing and outpatient medical sectors with demonstrated secular tailwinds—SHO portfolio SSNOI grew 20.5% YoY with 330 bps occupancy gains and 5.2% RevPOR growth, supporting the durability of cash flows. However, the portfolio shows moderate concentration risk: SHO represents the primary growth driver while OM dispositions ($1.9B YTD) signal strategic de-risking from a more competitive segment. The company is actively acquiring modern assets (Amica portfolio of 38 communities, development properties) in supply-constrained Canadian markets, but leverage at 2.99x net debt-to-EBITDA and ongoing portfolio rebalancing suggest the portfolio is transitioning rather than fully optimized. Tenant credit quality is not explicitly detailed, and the shift away from OM indicates sector-specific headwinds in that segment.
Management & capital allocation
Welltower demonstrates mixed capital allocation discipline. Positively, the company increased FFO per share 25% year-over-year and raised its dividend 15%, supported by $4 billion of capital sourced including below-market debt assumptions and accretive deployment. However, the earnings release shows significant equity issuances alongside debt to fund $15.5 billion of pro rata investments year-to-date, and the price-to-FFO multiple of 37.2x suggests dilution from past issuances has not been offset by exceptional per-share growth. The company repaid $700 million of debt with free cash flow but simultaneously issued C$1.15 billion in new notes, indicating ongoing capital market reliance rather than organic deleveraging. Disclosure is professional but lacks candid discussion of insider ownership or long-term per-share track record relative to asset growth.
Valuation
Mechanical valuation (D-07): current ratio 37.2 vs 12-point own history, percentile rank 0.83.
Score history
Event-anchoredIllustrative history — each point corresponds to a scoring trigger (filing, announcement, or initial coverage). At launch a name has a single point.
Sources
Sources are the exact documents used by this assessment, recorded when it ran.
Metric history
P/(A)FFOP/(A)FFO over time — 28 data points since Aug 2, 2026.
Scores are analytical opinions, not investment advice. Figures reflect the most recent data available as of the assessed date and may differ from current market values.